https://charts.traderzeitung.de/phases/US4330001060 string(1457) "{"isin":"US4330001060","name":"Hims & Hers Health Inc","stock_id":16776373,"generated_at":"2026-10-09 10:02:00","days":[{"date":"2026-10-07","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":28.92,"close_at":"2026-10-07 15:26:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":29.58,"close_at":"2026-10-07 21:59:00","complete":true,"perf_pct":2.2822},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":29.54,"close_at":"2026-10-08 01:14:00","complete":true,"perf_pct":-0.1352}]},{"date":"2026-10-08","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":29.25,"close_at":"2026-10-08 15:29:00","complete":true,"perf_pct":-0.9817},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":28.06,"close_at":"2026-10-08 21:59:00","complete":true,"perf_pct":-4.0684},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":28.09,"close_at":"2026-10-09 01:44:00","complete":true,"perf_pct":0.1069}]},{"date":"2026-10-09","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":28.38,"close_at":"2026-10-09 10:02:00","complete":false,"perf_pct":1.0324},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"

Hims & Hers Health Aktie News & Nachrichten

[WKN: A2QMYY | Symbol: HIMS]

Realtimekurs

09.03.2026 um 16 Uhr

Hims & Hers Health

Hims & Hers Health Aktie News & Nachrichten

Stocks in Action USA: Vertiv, Xenon Pharmaceuticals, Hims & Hers Health

Vom Gejagten zum Partner! Möglicher Mega-Deal mit Novo Nordisk zündet Kursfeuerwerk bei Hims & Hers!

Doppelschlag für Hims & Hers: SEC-Ermittlungen und schwacher Ausblick schicken Aktie auf Talfahrt

Stocks in Action USA: Kroger, Hims & Hers, STMicroelectronics

Blitz-K.O. vor dem Super Bowl! Hims & Hers stoppt Billig-Wegovy nach massiven Drohungen der FDA!

Super Bowl als Kurskatalysator: Hims & Hers setzt erneut auf maximale Aufmerksamkeit

Hims & Hers: Bringen Kanada-Expansion und Diagnostik-Deal die Trendwende?

Hims & Hers: Telemedizin gewinnt im Winter an zusätzlicher Bedeutung

Hims & Hers: Die Telemedizin-Aktie sollte man nach den jüngsten Quartalszahlen wieder verstärkt im Blick haben!

Hims & Hers: Novo-Deal rückt näher

Diagnostik, Langlebigkeit, Globalisierung – Hims & Hers plant großen Sprung nach vorn

Hims & Hers Health expandiert mit Hormonersatzprogrammen